🔎 Trials Near Me

Home › Spina Bifida › NCT07615686

tSCS in Children With Spina Bifida

Recruiting

Transcutaneous Spinal Cord Stimulation to Improve Strength and Gait in Children With Spina Bifida

Who can join

Ages 4 to 17 · All sexes

Full eligibility criteria
Inclusion Criteria:

* Diagnosed myelomeningocele confirmed by a neurosurgeon or neurologist
* Some difficulty ambulating, but able to ambulate at least a short distance (10 meters) with devices and/or assistance.
* Between the ages of 4 and 17 years of age.
* Documented neurogenic bladder dysfunction
* On a stable bladder management regimen at least 4-6 weeks prior to the enrollment in the trial

Exclusion Criteria:

* Severe behavioral or cognitive impairments that preclude participation in the study, in the opinion of the investigator.
* Has an active surgery planned for impairments from spina bifida (e.g. tethered cord syndrome surgery or orthopedic surgery) or has had surgery in the last 6 months.
* Is pregnant. Pregnancy will be assessed via verbal report.
* Open wounds at the thoracic or lumbar spine that precludes transcutaneous stimulation.
* Implanted or attached electronic device in any location of the body (e.g. pacemakers, baclofen pumps, or implanted insulin pumps)
* Symptomatic urinary tract infection, urinary tract infection for which they are currently receiving treatment, scheduled urological surgery, or inability to perform or receive catheterization.

About the study

A single-center, open-label, investigational pilot trial to explore potential effects of transcutaneous spinal cord stimulation on leg muscle strength and walking in children with myelomeningocele.

What is being tested

Sponsor: Bailey Petersen · Participants: 20 · Started: Sep 30, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07615686

Locations in the U.S.

PennsylvaniaUniversity of Pittsburgh, Pittsburgh

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.